The Obama administration said biogeneric drugs should be protected from competition for seven years, calling it a “generous compromise” between competing plans.
National Business News - Local Business News | bizjournals, Biz Journals
Mon, 06/29/2009 - 8:55am
The Obama administration said biogeneric drugs should be protected from competition for seven years, calling it a “generous compromise” between competing plans.